Trial Profile
Evaluate the Effect of Risk Factors That Influence the Immunogenicity of GSK Biologicals' Twinrix Compared to Hepatitis A and Hepatitis B Vaccines Given Separately and to Show the Non-inferiority Between the Vaccines in Adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2023
Price :
$35
*
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary) ; Hepatitis A vaccine inactivated; Hepatitis B vaccine recombinant
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 10 Nov 2016 New trial record